QID 38918

Date Published: 2024-02-08

QID 38918: Cisco Expressway Series Multiple Cross-Site Request Forgery (CSRF) Vulnerabilities (cisco-sa-expressway-csrf-KnnZDMj3)

Multiple vulnerabilities in the Cisco Expressway Series could allow an unauthenticated, remote attacker to conduct cross-site request forgery (CSRF) attacks, which could allow the attacker to perform arbitrary actions on an affected device.

Affected Products
Cisco Expressway Series prior to version 14.3.4

QID Detection Logic (Unauthenticated):
The check matches version of Cisco Expressway on the exposed banner information under the SIP banner.

Note: This is banner based detection and does not checks for the device configuration, hence QID is kept as practice.

These vulnerabilities may allow an unauthenticated, remote attacker to conduct cross-site request forgery (CSRF) attacks, which could allow the attacker to perform arbitrary actions on an affected device.

CVSS V3 rated as Critical - 8.8 severity.

CVSS V2 rated as Critical - 10 severity.

Solution

Customers are advised to refer to cisco-sa-expressway-csrf-KnnZDMj3 for more information.

Vendor References

cisco-sa-expressway-csrf-KnnZDMj3 - sec.cloudapps.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-expressway-csrf-KnnZDMj3

CVEs related to QID 38918

CVE-2024-20252 | CVE-2024-20254 | CVE-2024-20255 |

Software Advisories

Advisory ID	Software	Component	Link
cisco-sa-expressway-csrf-KnnZDMj3			sec.cloudapps.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-expressway-csrf-KnnZDMj3

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].